Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3

Phase 1 Completed 23 enrolled Vanderbilt University Medical Center

NaSingle-groupOpen-labelBasic science

Summary

This study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.

Timeline

Start: 2022-03-09
Primary completion: 2023-01-27
Completion: 2023-01-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	L-Lysine	Other / unclassified	5 g	Oral

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3

Summary

Timeline

Drugs

Indications